306 related articles for article (PubMed ID: 15868616)
21. Risk factors for development of coronary artery disease in women with systemic lupus erythematosus.
Goldberg RJ; Urowitz MB; Ibañez D; Nikpour M; Gladman DD
J Rheumatol; 2009 Nov; 36(11):2454-61. PubMed ID: 19833754
[TBL] [Abstract][Full Text] [Related]
22. Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus.
Von Feldt JM; Scalzi LV; Cucchiara AJ; Morthala S; Kealey C; Flagg SD; Genin A; Van Dyke AL; Nackos E; Chander A; Gehrie E; Cron RQ; Whitehead AS
Arthritis Rheum; 2006 Jul; 54(7):2220-7. PubMed ID: 16802358
[TBL] [Abstract][Full Text] [Related]
23. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study.
Mok CC; Ho LY; Cheung MY; Yu KL; To CH
Scand J Rheumatol; 2009; 38(2):121-7. PubMed ID: 18991189
[TBL] [Abstract][Full Text] [Related]
24. Item weightings for the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Disease Damage Index using Rasch analysis do not lead to an important improvement.
Brunner HI; Feldman BM; Urowitz MB; Gladman DD
J Rheumatol; 2003 Feb; 30(2):292-7. PubMed ID: 12563683
[TBL] [Abstract][Full Text] [Related]
25. SLEDAI-2K for a 30-day window.
Touma Z; Urowitz MB; Gladman DD
Lupus; 2010 Jan; 19(1):49-51. PubMed ID: 19910390
[TBL] [Abstract][Full Text] [Related]
26. Sensitivity of the Systemic Lupus Erythematosus Disease Activity Index, British Isles Lupus Assessment Group Index, and Systemic Lupus Activity Measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus.
Brunner HI; Feldman BM; Bombardier C; Silverman ED
Arthritis Rheum; 1999 Jul; 42(7):1354-60. PubMed ID: 10403262
[TBL] [Abstract][Full Text] [Related]
27. Greater accrual damage in late-onset systemic lupus erythematosus: a long-term follow-up study.
Appenzeller S; Pereira DA; Costallat LT
Lupus; 2008 Nov; 17(11):1023-8. PubMed ID: 18852227
[TBL] [Abstract][Full Text] [Related]
28. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXI. Disease activity, damage accrual, and vascular events in pre- and postmenopausal women.
Fernández M; Calvo-Alén J; Alarcón GS; Roseman JM; Bastian HM; Fessler BJ; McGwin G; Vilá LM; Sanchez ML; Reveille JD
Arthritis Rheum; 2005 Jun; 52(6):1655-64. PubMed ID: 15934092
[TBL] [Abstract][Full Text] [Related]
29. Coronary calcium in systemic lupus erythematosus is associated with traditional cardiovascular risk factors, but not with disease activity.
Kiani AN; Magder L; Petri M
J Rheumatol; 2008 Jul; 35(7):1300-6. PubMed ID: 18484694
[TBL] [Abstract][Full Text] [Related]
30. Disease activity as a major risk factor for osteonecrosis in early systemic lupus erythematosus.
Fialho SC; Bonfá E; Vitule LF; D'Amico E; Caparbo V; Gualandro S; Pereira RM
Lupus; 2007; 16(4):239-44. PubMed ID: 17439929
[TBL] [Abstract][Full Text] [Related]
31. Prolonged remission in systemic lupus erythematosus.
Urowitz MB; Feletar M; Bruce IN; Ibañez D; Gladman DD
J Rheumatol; 2005 Aug; 32(8):1467-72. PubMed ID: 16078321
[TBL] [Abstract][Full Text] [Related]
32. Fatigue in lupus is not correlated with disease activity.
Wang B; Gladman DD; Urowitz MB
J Rheumatol; 1998 May; 25(5):892-5. PubMed ID: 9598886
[TBL] [Abstract][Full Text] [Related]
33. Recent corticosteroid use and recent disease activity: independent determinants of coronary heart disease risk factors in systemic lupus erythematosus?
Karp I; Abrahamowicz M; Fortin PR; Pilote L; Neville C; Pineau CA; Esdaile JM
Arthritis Rheum; 2008 Feb; 59(2):169-75. PubMed ID: 18240259
[TBL] [Abstract][Full Text] [Related]
34. Elevated levels of serum soluble Fas are associated with organ and tissue damage in systemic lupus erythematosus among Chinese.
Hao JH; Ye DQ; Zhang GQ; Liu HH; Dai H; Huang F; Pan FM; Su H; Dong MX; Chen H; Wang Q; Zhang XJ
Arch Dermatol Res; 2006 Jan; 297(7):329-32. PubMed ID: 16328345
[TBL] [Abstract][Full Text] [Related]
35. Autonomic dysfunction in patients with systemic lupus erythematosus.
Gamez-Nava JI; Gonzalez-Lopez L; Ramos-Remus C; Fonseca-Gomez MM; Cardona-Muñoz EG; Suarez-Almazor ME
J Rheumatol; 1998 Jun; 25(6):1092-6. PubMed ID: 9632069
[TBL] [Abstract][Full Text] [Related]
36. Lack of subclinical myocardial ischaemia in Mexican patients with systemic lupus erythematosus without traditional risk factors for coronary artery disease.
García-Carrasco M; Escárcega RO; Pérez-Terrón J; Ramírez A; Muñoz-Guarneros M; Beltrán A; Pérez-Cuevas B; López-Colombo A; Cervera R
Lupus; 2007; 16(4):298-301. PubMed ID: 17439938
[TBL] [Abstract][Full Text] [Related]
37. Influenza virus vaccination of patients with systemic lupus erythematosus: effects on disease activity.
Abu-Shakra M; Zalmanson S; Neumann L; Flusser D; Sukenik S; Buskila D
J Rheumatol; 2000 Jul; 27(7):1681-5. PubMed ID: 10914851
[TBL] [Abstract][Full Text] [Related]
38. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease.
Souza A; da Silva LM; Oliveira FR; Roselino AM; Louzada-Junior P
Lupus; 2009 Mar; 18(3):223-9. PubMed ID: 19213860
[TBL] [Abstract][Full Text] [Related]
39. Development and testing of a systemic lupus-specific risk adjustment index for in-hospital mortality.
Ward MM
J Rheumatol; 2000 Jun; 27(6):1408-13. PubMed ID: 10852262
[TBL] [Abstract][Full Text] [Related]
40. Sensitivity to change of 3 Systemic Lupus Erythematosus Disease Activity Indices: international validation.
Gladman DD; Goldsmith CH; Urowitz MB; Bacon P; Bombardier C; Isenberg D; Kalunian K; Liang MH; Maddison P; Nived O
J Rheumatol; 1994 Aug; 21(8):1468-71. PubMed ID: 7983648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
